Search
for
Sort by
Research 211–240 of 1000+
- 61349 The Development of Vitiligo After Cessation of Finasteride: Is this Part of Post-Finasteride Syndrome or an Adverse Event of Finasteride?
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Microneedling and Its Use in Hair Loss Disorders: A Systematic Review
- Comparison of a New 5% Minoxidil Foam and Rogaine® in the Treatment of Androgenetic Alopecia in Chinese Men: A Randomized, Double-Blind, Phase III, Equivalence Trial
- JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study
- Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review
- Sorafenib-Associated Facial Acneiform Eruption
- Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children
- Physiological and biological skin changes in pregnancy
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Complex Hair Cycle Domain Patterns and Regenerative Hair Waves in Living Rodents
- Topical valproic acid increases the hair count in male patients with androgenetic alopecia: A randomized, comparative, clinical feasibility study using phototrichogram analysis
- Hormonal therapies for acne
- Deoxycholic acid in the submental fat reduction: A review of properties, adverse effects, and complications
- Many Paths to Alopecia via Compromised Regeneration of Hair Follicle Stem Cells
- Efficacy of superficial cryotherapy on the eyebrows of patients with alopecia universalis also treated with contact immunotherapy on the scalp: a prospective, split‐face comparative study
- Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
- Comparative efficacy and safety of platelet-rich plasma (PRP), injectable platelet-rich fibrin (i-PRF) and concentrated growth factors (CGF) for female pattern hair loss (FPHL): a prospective multicenter randomized clinical trial
- Safety and use of oral minoxidil in pediatric patients: a systematic review and meta-analysis
- Patient‐reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data
- Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Investigator‐blinded, controlled, and randomized comparative study on 1565 nm non‐ablative fractional laser versus 5% minoxidil for treatment of androgenetic alopecia
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis
- Psychosomatic aspects of alopecia areata